Brainstorm Cell Therapeutics Inc. Stock price
Is Brainstorm Cell Therapeutics Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.
Key metrics
Brainstorm Cell Therapeutics Inc. Stock Analysis
Analyst Opinions
6 Analysts have issued a Brainstorm Cell Therapeutics Inc. forecast:
Analyst Opinions
6 Analysts have issued a Brainstorm Cell Therapeutics Inc. forecast:
Don't miss a Thing! We will send you all news about Brainstorm Cell Therapeutics Inc. directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Brainstorm Cell Therapeutics Inc. Stock News
Company Profile
Brainstorm Cell Therapeutics, Inc. operates as a biotechnology company, which develops and commercializes adult stem cell therapeutic products. It focuses on utilizing the patients own bone marrow stem cells to generate neuron-like cells that may provide an effective treatment initially for amyotrophic lateral sclerosis, Parkinson's disease, multiple sclerosis and spinal cord injury. The company was founded on September 22, 2000 and is headquartered in New York, NJ.
| Head office | United States |
| CEO | Mr. Lebovits |
| Employees | 23 |
| Founded | 2000 |
| Website | brainstorm-cell.com |


